I forgot to mention that I bought shares @ $1.15.
Obesity drug AOD9604:
Patients will be enrolled for the all important Phase IIb trial to start in October and spread over four hospitals.
Duration: three months only. Just about every man and his dog has applied for enrolment so there shouldn't be any hold-ups.
This drug could be of great importance.
Gerry
- Forums
- ASX - By Stock
- MBP
- + data and comment +
+ data and comment +, page-2
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)